trim ep
oper show volatil despit
favor macro backdrop lower price target
ebitda expect upcom investor day reaffirm baselin
rather confirm inflect narr share like remain
range-bound best demand outlook clarifi next spring
review ep lower expect safeti graphic
industri health consum corpor electron in-
line off-set lower tax non-oper item sale declin
volume price fx organ growth asia
latin america us europ segment level organ growth
mix outgrew electron industri
 health despit china develop market
consum
posit price continu outpac raw materi tailwind margin
benefit yoy erp roll-out cover sale -- though roll-
clip us growth estim split
 buyback could add ep year rel strong
end-market includ advanc materi ex-f/x industri adhes tape
person tough comparison transport health inform
neg fx headwind estim revis
lower tariff headwind next-year raw materi
headwind vs prior expect flag
cost escal weak end-market includ auto aftermarket
consum health care drug deliveri due custom product cycl
stabil year home care offic suppli roof granul downstream
deceler stationeri expect chines deceler industri consum
spill broader theme downstream inventori destock like
continu
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
tailwind pension
ebit margin yoy
 expect
invest thesi hing compani
sustain sale momentum without divis fade
way last cycl stabl margin
maintain margin match consensu ep
robust demand environ lead growth
volum grow ahead
margin expand price outpac raw materi
share trade line long-term averag peak
data demonstr new product introduct
translat sale growth spin wheel
year growth slow due mid-decad
recess volum declin per year
margin compress due raw materi pressur
increment benefit use
share trade line long-term averag trough
page
pleas see import disclosur inform page report
